Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Ranitidine
|
| gptkbp:appointed_by |
intravenous route
oral route |
| gptkbp:breathability |
gptkb:theorem
|
| gptkbp:can_be_used_with |
other medications
|
| gptkbp:contraindication |
certain heart conditions
seizure disorders |
| gptkbp:developed_by |
tea leaves
|
| gptkbp:discovered_by |
1888
|
| gptkbp:enhances |
diaphragmatic contractility
|
| gptkbp:game_components |
some cough syrups
|
| https://www.w3.org/2000/01/rdf-schema#label |
Theophylline
|
| gptkbp:ingredients |
C7 H8 N4 O2
|
| gptkbp:interacts_with |
antidepressants
certain antibiotics |
| gptkbp:is_associated_with |
gastroesophageal reflux
increased risk of arrhythmias |
| gptkbp:is_available_in |
liquid form
tablet form injection form |
| gptkbp:is_available_on |
immediate-release formulation
sustained-release formulation |
| gptkbp:is_effective_against |
relieving bronchospasm
|
| gptkbp:is_found_in |
coffee beans
cacao beans guarana |
| gptkbp:is_monitored_by |
blood tests
|
| gptkbp:is_often_used_in |
chronic cough
sleep apnea apnea in premature infants exercise-induced bronchoconstriction other bronchodilators |
| gptkbp:is_part_of |
theophylline therapy
theophylline-based therapies |
| gptkbp:is_related_to |
theobromine
caffeine |
| gptkbp:is_used_for |
gptkb:asthma
chronic obstructive pulmonary disease |
| gptkbp:is_used_in |
palliative care
clinical research emergency medicine pulmonary rehabilitation respiratory therapy clinical guidelines for asthma management |
| gptkbp:is_vulnerable_to |
gptkb:theorem
|
| gptkbp:lifespan |
3 to 7 hours
|
| gptkbp:metabolism |
liver
|
| gptkbp:pharmacokinetics |
gptkb:theorem
|
| gptkbp:products |
xanthine metabolism
|
| gptkbp:regulates |
gptkb:FDA
|
| gptkbp:scientific_classification |
a prescription drug
|
| gptkbp:side_effect |
nausea
insomnia increased heart rate |
| gptkbp:type_of |
gptkb:xanthine
|
| gptkbp:venomous |
gptkb:theorem
|